US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Norwegian Cruise Line, Wix.com rise; Cushman & Wakefield, Target fall, Monday, 5/20/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Monday:Johnson Contro2024-05-21Bustling Lantern Festival witnesses China's economic vitality and creativity
(ECNS) -- The Lantern Festival, celebrated on the fifteenth day of the first lunar month, falls on F2024-05-21China urges U.S. to stop COVID
National flags of China (R) and the United States. (Xinhua/Bao Dandan)BEIJING, July 6 (Xinhua) -- Ch2024-05-21Insights丨Experts call for a fair reading of China’s prospect
By Chen Tianhao, Feng Shuang(ECNS) -- With China and the U.S. contribution to the world GDP coming o2024-05-21Russian theater director and playwright go on trial over a play authorities say justifies terrorism
TALLINN, Estonia (AP) — A Russian court on Monday opened the trial of a theater director and a playw2024-05-21EU condemns Turkish decision to convert Hagia Sophia back to mosque
EU's High Representative for Foreign Affairs and Security Policy Josep Borrell speaks during a press2024-05-21
atest comment